Form 4: Arteris CFO Sells Shares Under 10b5-1 Plan

Arteris, Inc.'s CFO, Nicholas B. Hawkins, sold 11,276 shares of common stock for approximately $13.15 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc. (AIP), sold 11,276 shares of the company's common stock.
• The transaction occurred on August 5, 2025.
• The shares were sold at a weighted average price of $13.1505 per share, with individual sales ranging from $12.34 to $14.20.
• This sale was executed under a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
• Following this transaction, Mr. Hawkins beneficially owns 107,996 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: Neutral. A routine insider sale under a pre-arranged 10b5-1 plan, which is typically not indicative of new positive or negative company developments.

Industry Context

This filing is a routine insider transaction disclosure, reflecting a pre-planned sale by a corporate officer rather than a reaction to new company or industry developments.

Stakeholder Impact

• Shareholders: The sale reduces the CFO's direct beneficial ownership, but as it was pre-planned under a 10b5-1 plan, it is generally not viewed as a negative signal regarding the company's future prospects.

Key Dates

Recommendation

The filing is a routine Form 4 disclosing a pre-planned sale by a CFO under a 10b5-1 plan. Such sales are typically for personal financial planning and do not reflect a change in the company's fundamentals or outlook. Therefore, it provides no new information to warrant a change in investment recommendation.

Keywords

Arteris Inc., AIP, Form 4, Insider Trading, Stock Sale, Nicholas B. Hawkins, 10b5-1 Plan, CFO, Beneficial Ownership